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Thymoquinone rich fraction from Nigella sativa and thymoquinone are cytotoxic 
towards colon and leukemic carcinoma cell lines. 
 
ABSTRACT 
Nigella sativa has been used for centuries in Asia, Middle East and Africa to promote health 
and fight diseases. In this study, the anti-cancer effects of thymoquinone rich fraction 
(TQRF) extracted from N. sativa seeds using supercritical fluid extraction (SFE) system and 
commercially available thymoquinone (TQ) on colon cancer (HT29), lymphoblastic leukemia 
(CEMSS) and promyelocytic leukemia (HL60) cells lines were investigated. The 
concentration that gave 50% inhibition of cell viability (IC50) of HT29, CEMSS and HL60 
cells treated with TQRF were 400, 350 and 250 µg/ml, respectively. Meanwhile, the IC50 of 
TQ was 8, 5 and 3 µg/ml, respectively. Cell cycle analysis shows the increment of apoptosis 
in a time-dependent manner. However, both TQRF and TQ were not able to arrest the cell 
cycle phases of the cells. Apoptosis was the main mode of HT29, CEMSS and HL60 cells 
death induced by both TQRF and TQ. Our findings support the potential use of TQRF and 
TQ for the treatment of colon cancer and leukemia. 
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